Net Cash Provided by (Used in) Operating Activities |
396K |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-526K |
USD |
-120% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-635K |
USD |
+62.9% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
900M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
10M |
shares |
+0.44% |
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-765K |
USD |
-798% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
9.5M |
USD |
-27.3% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
3.08M |
USD |
-36.6% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
10.5M |
USD |
+20.5% |
Q4 2024 |
FY 2024 |
Depreciation |
2.56M |
USD |
+5.42% |
Q1 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-42.7K |
USD |
+49.5% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
97.9M |
USD |
+0.46% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
Share-based Payment Arrangement, Expense |
42.3K |
USD |
0% |
Q1 2025 |
Q1 2025 |
Interest Expense |
18.5M |
USD |
+23.7% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |